Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000092584

Apexbio Technology LLC Clindamycin Phosphate 24729-96-2 10mM (in 1mL H2O)
SDP

Catalog No. 5000092584
Encompass_Preferred

Clindamycin Phosphate (CAS 24729-96-2) is a prodrug derivative of clindamycin from the lincosamide antibiotic class It is designed to undergo enzymatic hydrolysis in vivo to release active clindamycin which inhibits bacterial protein synthesis by binding to ribosomal subunits exerting bacteriostatic effects Clindamycin Phosphate exhibits no direct antibacterial activity in vitro but demonstrates bacteriostatic activity upon hydrolysis to clindamycin Reported IC50 values of clindamycin against sensitive bacterial strains are typically in the low micromolar concentration range Based on these pharmacological properties Clindamycin Phosphate holds research potential in studies focused on microbial pathogens associated with skin infections acne and bacterial vaginosis It has also been assessed in combination strategies such as coupling with platelet-rich fibrin (PRF) to enhance antibacterial capacity without observable cytotoxicity

Catalog No. 50-000-92584 Supplier Apexbio Technology LLC Supplier No. B17085.1
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Clindamycin Phosphate (CAS 24729-96-2) is a prodrug derivative of clindamycin from the lincosamide antibiotic class It is designed to undergo enzymatic hydrolysis in vivo to release active clindamycin which inhibits bacterial protein synthesis by binding to ribosomal subunits exerting bacteriostatic effects Clindamycin Phosphate exhibits no direct antibacterial activity in vitro but demonstrates bacteriostatic activity upon hydrolysis to clindamycin Reported IC50 values of clindamycin against sensitive bacterial strains are typically in the low micromolar concentration range Based on these pharmacological properties Clindamycin Phosphate holds research potential in studies focused on microbial pathogens associated with skin infections acne and bacterial vaginosis It has also been assessed in combination strategies such as coupling with platelet-rich fibrin (PRF) to enhance antibacterial capacity without observable cytotoxicity

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.